Combination therapy: some concepts and results.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D002648:Child; D003510:Cyclohexanes / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use / Q000633:toxicity; D003609:Dactinomycin / Q000627:therapeutic use; D004351:Drug Resistance; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy / Q000601:surgery; D008545:Melanoma / Q000188:drug therapy / Q000601:surgery; D051379:Mice; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000601:surgery / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000601:surgery; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use / Q000633:toxicity; D014226:Triazenes / Q000627:therapeutic use; D009396:Wilms Tumor / Q000532:radiotherapy / Q000601:surgery
D000970:Antineoplastic Agents; D003510:Cyclohexanes; D007093:Imidazoles; D009588:Nitrogen Mustard Compounds; D009607:Nitrosourea Compounds; D014226:Triazenes; D003561:Cytarabine; D003609:Dactinomycin; D003520:Cyclophosphamide; D013866:Thioguanine